Загрузка...
Can We Rely on the Activated Clotting Time to Measure Heparin Anticoagulation? A Clinical Evaluation of Two ACT Monitors
The sensitivity to heparin during cardiopulmonary bypass (CPB) is determined by patient-specific characteristics and is assessed by the whole blood activated clotting time (ACT). We aimed to examine reliability measures between two different ACT monitors using Bland–Altman analysis: bias should not...
Сохранить в:
| Опубликовано в: : | J Extra Corpor Technol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of ExtraCorporeal Technology
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7499231/ https://ncbi.nlm.nih.gov/pubmed/32981959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/ject-2000005 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|